이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Hepion Pharmaceuticals 관리
관리 기준 확인 2/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
John Brancaccio
최고 경영자
US$81.0k
총 보상
CEO 급여 비율 | n/a |
CEO 임기 | less than a year |
CEO 소유권 | 0.006% |
경영진 평균 재임 기간 | 데이터 없음 |
이사회 평균 재임 기간 | 2yrs |
최근 관리 업데이트
Recent updates
Hepion Pharmaceuticals (NASDAQ:HEPA) Will Have To Spend Its Cash Wisely
Aug 10We're Keeping An Eye On Hepion Pharmaceuticals' (NASDAQ:HEPA) Cash Burn Rate
Apr 25We're Keeping An Eye On Hepion Pharmaceuticals' (NASDAQ:HEPA) Cash Burn Rate
Oct 27Hepion Pharma rises as company begins NASH treatment trial
Aug 31Will Hepion Pharmaceuticals (NASDAQ:HEPA) Spend Its Cash Wisely?
Jul 04Hepion Pharmaceuticals CEO Robert Foster - Dash To Beat NASH
Feb 17Hepion Pharmaceuticals: Facing The Momentous Year 2022
Jan 21Additional Phase IIa Data Confirms Hepion's CRV431 As A Very Promising NASH Candidate Drug
Sep 21Companies Like Hepion Pharmaceuticals (NASDAQ:HEPA) Are In A Position To Invest In Growth
Sep 14Hepion Pharmaceuticals: A Promising Early-Stage Biopharma In The NASH Race
Sep 08Treating Chronic Liver Disease - Interview With Hepion Pharmaceuticals CEO Dr. Robert Foster (Video)
May 26What Type Of Shareholders Make Up Hepion Pharmaceuticals, Inc.'s (NASDAQ:HEPA) Share Registry?
Feb 18Hepion Pharma cleared to advance final dosing cohort in NASH trial
Dec 29Hepion Pharma to begin CRV431 testing in COVID-19 patients
Dec 22Dosing underway in higher dose cohort with Hepion's CRV431 in NASH study
Dec 10Hepion Pharma prices equity offering at $1.50
Nov 25Hepion Pharmaceuticals (HEPA) Investor Presentation - Slideshow
Oct 31CEO
John Brancaccio (76 yo)
less than a year
테뉴어
US$81,000
보상
Mr. John Patrick Brancaccio, C.P.A, serves as Independent Non-Executive Director at Tiziana Life Sciences plc since July 2020. He is an Independent Non-Executive Director at OKYO Pharma Limited since June...
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
Interim CEO | 11.4yrs | US$81.00k | 0.0060% $ 224.1 | |
Independent Director | 10.9yrs | US$72.90k | 0.0060% $ 224.1 | |
Member of Scientific Advisory Board | 1.6yrs | 데이터 없음 | 데이터 없음 | |
Member of Scientific Advisory Board | 1.6yrs | 데이터 없음 | 데이터 없음 | |
Scientific Advisory Board Chair | 5.2yrs | 데이터 없음 | 데이터 없음 | |
Member of Scientific Advisory Board | 1.6yrs | 데이터 없음 | 데이터 없음 | |
Member of Scientific Advisory Board | 8.3yrs | 데이터 없음 | 데이터 없음 | |
Independent Director | less than a year | 데이터 없음 | 데이터 없음 | |
Member of Scientific Advisory Board | 1.6yrs | 데이터 없음 | 데이터 없음 | |
Independent Director | 2.3yrs | US$80.50k | 데이터 없음 |
2.0yrs
평균 재임 기간
68yo
평균 연령
경험이 풍부한 이사회: HEPA 의 이사회는 경험(평균 재직 기간 1.8 년)으로 간주되지 않으므로 새 이사회가 필요합니다.